Search hospitals
>
Virginia
>
Fairfax
INOVA Fair Oaks Hospital
Claim this profile
Fairfax, Virginia 22033
Conducts research for Breast Cancer
Conducts research for Pancreatic Cancer
Conducts research for Breast cancer
Conducts research for Lung Cancer
Conducts research for Skin Cancer
26 reported clinical trials
15 medical researchers
Summary
INOVA Fair Oaks Hospital is a medical facility located in Fairfax, Virginia. This center is recognized for care of Breast Cancer, Pancreatic Cancer, Breast cancer, Lung Cancer, Skin Cancer and other specialties. INOVA Fair Oaks Hospital is involved with conducting 26 clinical trials across 78 conditions. There are 15 research doctors associated with this hospital, such as Adam Cohen, MD, Timothy L. Cannon, Raymond C Wadlow, MD, and Kathleen K. Harnden.
Area of expertise
Breast Cancer
INOVA Fair Oaks Hospital has run 10 trials for Breast Cancer. Some of their research focus areas include:
Pancreatic Cancer
INOVA Fair Oaks Hospital has run 8 trials for Pancreatic Cancer. Some of their research focus areas include:
Top PIs
Adam Cohen, MD
Inova Schar Cancer Institute
2 years of reported clinical research
Timothy L. Cannon
Inova Schar Cancer Institute
4 years of reported clinical research
Raymond C Wadlow, MD
Inova Schar Cancer Institute
3 years of reported clinical research
Kathleen K. Harnden
Inova Schar Cancer Institute
2 years of reported clinical research
Clinical Trials running at INOVA Fair Oaks Hospital
Pancreatic Cancer
Lung Cancer
Esophageal cancer
Breast Cancer
Gastroesophageal Junction Adenocarcinoma
Esophageal Carcinoma
Pancreatic Carcinoma
Breast cancer
Esophageal Adenocarcinoma
Esophageal Cancer
Perioperative Chemotherapy
for Pancreatic Cancer
This phase III trial compares perioperative chemotherapy (given before and after surgery) versus adjuvant chemotherapy (given after surgery) for the treatment of pancreatic cancer that can be removed by surgery (removable/resectable). Chemotherapy drugs, such as fluorouracil, irinotecan, leucovorin, and oxaliplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving chemotherapy before and after surgery (perioperatively) may work better in treating patients with pancreatic cancer compared to giving chemotherapy after surgery (adjuvantly).
Recruiting
4 awards
Phase 3
18 criteria
Higher Dose Radiation Therapy
for Pancreatic Cancer
This phase III trial compares the effect of dose-escalated radiation therapy to usual care in patients with locally advanced unresectable pancreatic ductal adenocarcinoma who have received an initial 4-6 months of chemotherapy. Usual care options include additional chemotherapy, observation, or standard lower-dose radiation therapy. These treatments may delay tumor growth but have not been shown to improve survival. Radiation therapy uses high energy X-rays to kill cancer cells and shrink tumors. Dose-escalated radiation therapy involves the precise delivery of higher doses to the tumor, often over a shorter period of time. This trial assesses whether using dose-escalated radiation therapy can prolong survival.
Recruiting
2 awards
Phase 3
6 criteria
Radiation Therapy
for Cancer with Bone Metastasis
This phase III trial compares the effect of adding radiation therapy to usual care on the occurrence of bone-related complications in cancer patients with high-risk bone metastases that are not causing symptoms (asymptomatic). High-risk bone metastases are defined by their location (including hip, shoulder, long bones, and certain levels of the spine), or size (2 cm or larger). These bone metastases appear to be at higher risk of complications such as fracture, spinal cord compression, and/or pain warranting surgery or radiation treatment. Radiation therapy uses high energy x-rays to kill cancer cells and shrink tumors. The total dose of radiation can be delivered in a single day or divided in smaller doses for up to 5 days of total treatment. Usual care for asymptomatic bone metastases may include drugs that prevent bone loss, in addition to the treatment for the primary cancer or observation (which means no treatment until symptoms appear). Evidence has shown that preventative radiation therapy may be effective in lowering the number of bone metastases-related complications, however, it is not known if this approach is superior to usual care. Adding radiation therapy to usual care may be more effective in preventing bone-related complications than usual care alone in cancer patients with asymptomatic high-risk bone metastases.
Recruiting
2 awards
Phase 3
7 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at INOVA Fair Oaks Hospital?
INOVA Fair Oaks Hospital is a medical facility located in Fairfax, Virginia. This center is recognized for care of Breast Cancer, Pancreatic Cancer, Breast cancer, Lung Cancer, Skin Cancer and other specialties. INOVA Fair Oaks Hospital is involved with conducting 26 clinical trials across 78 conditions. There are 15 research doctors associated with this hospital, such as Adam Cohen, MD, Timothy L. Cannon, Raymond C Wadlow, MD, and Kathleen K. Harnden.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.